findmyKOL

Robert Rothbard, MD

Basic profile

Interventional Cardiology

ORCIDNone on fileNPI↗
✓ Full record
RegionOrlando, FL · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2022findmyKOL type: RegionalLatest publication1990Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Rothbard is a Cardiology physician. OpenAlex indexes 15 publications with 411 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex.

411citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2320 N Orange Ave
Orlando, FL 32804

Telephone

407-896-0054

Provider last certified this registry record 9 Jun 2022.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.6%
    Statin19.8%
    Rosuvastatin Calcium51%Atorvastatin Calcium49%
    Part D≥37 patients
    Beta blocker18.6%
    Metoprolol Succinate70%Atenolol30%
    Part D≥43 patients

    + 5 more classes in this area

  • Blood & clotting

    18.6%
    Factor Xa inhibitor14.8%
    Eliquis100%
    Part D≥21 patients
    P2Y12 inhibitor3.8%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.8%
    Potassium supplement2.8%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B), 20230% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”